Stephanie Griffith-Richards
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Stephanie Griffith-Richards has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Gerhard Walzl
Stellenbosch University, South Africa
3 shared publications - James Warwick
Nuclear Medicine Division, Department of Medical Imaging and Clinical Oncology, Stellenbosch University, Cape Town, South Africa
3 shared publications - Andre Gareth Loxton
DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
2 shared publications - Annare Ellmann
Division of Nuclear Medicine, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
2 shared publications - Brian W. Allwood
Division of Pulmonology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa
2 shared publications - Caroline Gina Gracieuse Beltran
Stellenbosch University, South Africa
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of the Colleges of Medicine of South Africa
- Vol. 4 (1) , 8
The impact of technical factors on the chest radiographic findings in COVID-19 pneumonia
Background: Published coronavirus disease 2019 (COVID-19) chest X-ray (CXR) severity scoring systems do not consider the impact of technical factors on radiographic findings. This study aimed to describe the technical features of COVID-19 pneumonia CXRs, determine their impact on CXR interpretation and reappraise published COVID-19 CXR severity scoring systems based on these findings. Methods: Admission frontal CXRs of 100 consecutive adults with proven COVID-19 pneumonia were analysed for technical features (projection, inspiratory excursion, exposure, vertical rotation) and pulmonary opacification. Descriptive statistics were evaluated. Kendall’s coefficient of concordance was used to assess observer agreement. One-way analysis of variance (ANOVA) was used to determine the association between technical factors and opacification. Levene’s test for homogeneity-of-variance and the Welch test were conducted where applicable. For inspiratory excursion, correlations were also calculated. Findings informed a review of published COVID-19 CXR severity scoring systems. Results: Poor inspiratory excursion obscured the lower lung zones in 41 cases and was associated with increased opacification in the visible (mid and upper) zones. Under- (n = 13) and over-penetration (n = 39) were associated with increased and decreased basal opacification, respectively. Eighty cases (80%) showed vertical rotation, without significant impact on opacification. Re-appraisal of published COVID-19 CXR scoring systems revealed that all simply assessed the visible lung fields, without considering inspiration or penetration. Conclusion: Published COVID-19 CXR severity scoring systems could be refined by appropriate consideration of inspiratory excursion and penetration. More broadly, technical considerations should inform all CXR interpretation. Contribution: This study advocates incorporating technical factor assessment into CXR severity scoring systems.
- 1 January 2026
- Published by AOSIS in Journal of the Colleges of Medicine of South Africa
- Vol. 4 (1) , 8
Open AccessThe impact of technical factors on the chest radiographic findings in COVID-19 pneumonia
Background: Published coronavirus disease 2019 (COVID-19) chest X-ray (CXR) severity scoring systems do not consider the impact of technical factors on radiographic findings. This study aimed to describe the technical features of COVID-19 pneumonia CXRs, determine their impact on CXR interpretation and reappraise published COVID-19 CXR severity scoring systems based on these findings. Methods: Admission frontal CXRs of 100 consecutive adults with proven COVID-19 pneumonia were analysed for technical features (projection, inspiratory excursion, exposure, vertical rotation) and pulmonary opacification. Descriptive statistics were evaluated. Kendall’s coefficient of concordance was used to assess observer agreement. One-way analysis of variance (ANOVA) was used to determine the association between technical factors and opacification. Levene’s test for homogeneity-of-variance and the Welch test were conducted where applicable. For inspiratory excursion, correlations were also calculated. Findings informed a review of published COVID-19 CXR severity scoring systems. Results: Poor inspiratory excursion obscured the lower lung zones in 41 cases and was associated with increased opacification in the visible (mid and upper) zones. Under- (n = 13) and over-penetration (n = 39) were associated with increased and decreased basal opacification, respectively. Eighty cases (80%) showed vertical rotation, without significant impact on opacification. Re-appraisal of published COVID-19 CXR scoring systems revealed that all simply assessed the visible lung fields, without considering inspiration or penetration. Conclusion: Published COVID-19 CXR severity scoring systems could be refined by appropriate consideration of inspiratory excursion and penetration. More broadly, technical considerations should inform all CXR interpretation. Contribution: This study advocates incorporating technical factor assessment into CXR severity scoring systems.
- Open Access
- 28 March 2025
- Published by South African Medical Association NPC in African Journal of Thoracic and Critical Care Medicine
- Vol. 31 (1) , e1948
Computed tomography chest imaging for the detection of pulmonary hypertension in patients with post-tuberculosis lung disease
Background. Pulmonary hypertension (PH) after tuberculosis is increasingly recognised as important in high-burden tuberculosis settings. However, the ability of computed tomography (CT) imaging to accurately detect PH remains unclear. Objectives. To evaluate the performance of standard CT measurements in detecting PH in patients with post-tuberculosis lung disease (PTLD), and to determine the potential role of CT imaging as a screening tool in this population. Methods. A retrospective study of patients with PTLD was conducted from January 2019 to September 2021. Adult patients with both a CT chest scan and an echocardiogram performed within 9 months of each other were enrolled. A diagnosis of PH by echocardiography was made if the right ventricular systolic pressure (RVSP) was ≥36 mmHg or the peak tricuspid regurgitant jet velocity (TRVmax) >2.8 m/s. Radiological criteria for PH included a pulmonary artery/ascending aorta (PA/AA) diameter ratio >1, pulmonary artery diameter (PAD) ≥29 mm (males) or ≥27 mm (females), and right ventricle/left ventricle (RV/LV) diameter ratio ≥1.28. Spirometry was also performed. Results. Of 173 patients with PTLD, 52 met the inclusion criteria. Significant correlations were found between the CT-measured PA/AA ratio and RVSP (p=0.0083) and TRVmax (p=0.0582), but not between the CT-measured RV/LV ratio and RVSP (p=0.1729) or TRVmax (p=0.0749). PAD was also significantly correlated with RVSP (p=0.0011) and TRVmax (p=0.0023). The PA/AA ratio identified patients with PH on echocardiography with ~100% sensitivity, 65% specificity and a positive predictive value of 39.1%, indicating a high potential for false-positive diagnosis. The forced vital capacity was 13.7% lower in patients with PH than in those without (p=0.044); however, the forced expiratory volume in 1 second was not statistically different. Conclusion. A low PA/AA ratio can be used to rule out the diagnosis of PH in PTLD, but a high PA/AA ratio requires further investigation for PH.
- 28 March 2025
- Published by South African Medical Association NPC in African Journal of Thoracic and Critical Care Medicine
- Vol. 31 (1) , e1948
Open AccessComputed tomography chest imaging for the detection of pulmonary hypertension in patients with post-tuberculosis lung disease
Background. Pulmonary hypertension (PH) after tuberculosis is increasingly recognised as important in high-burden tuberculosis settings. However, the ability of computed tomography (CT) imaging to accurately detect PH remains unclear. Objectives. To evaluate the performance of standard CT measurements in detecting PH in patients with post-tuberculosis lung disease (PTLD), and to determine the potential role of CT imaging as a screening tool in this population. Methods. A retrospective study of patients with PTLD was conducted from January 2019 to September 2021. Adult patients with both a CT chest scan and an echocardiogram performed within 9 months of each other were enrolled. A diagnosis of PH by echocardiography was made if the right ventricular systolic pressure (RVSP) was ≥36 mmHg or the peak tricuspid regurgitant jet velocity (TRVmax) >2.8 m/s. Radiological criteria for PH included a pulmonary artery/ascending aorta (PA/AA) diameter ratio >1, pulmonary artery diameter (PAD) ≥29 mm (males) or ≥27 mm (females), and right ventricle/left ventricle (RV/LV) diameter ratio ≥1.28. Spirometry was also performed. Results. Of 173 patients with PTLD, 52 met the inclusion criteria. Significant correlations were found between the CT-measured PA/AA ratio and RVSP (p=0.0083) and TRVmax (p=0.0582), but not between the CT-measured RV/LV ratio and RVSP (p=0.1729) or TRVmax (p=0.0749). PAD was also significantly correlated with RVSP (p=0.0011) and TRVmax (p=0.0023). The PA/AA ratio identified patients with PH on echocardiography with ~100% sensitivity, 65% specificity and a positive predictive value of 39.1%, indicating a high potential for false-positive diagnosis. The forced vital capacity was 13.7% lower in patients with PH than in those without (p=0.044); however, the forced expiratory volume in 1 second was not statistically different. Conclusion. A low PA/AA ratio can be used to rule out the diagnosis of PH in PTLD, but a high PA/AA ratio requires further investigation for PH.
- Open Access
- 1 January 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (1) , 320-332
A retrospective study exploring chronic pulmonary aspergillosis in post-tuberculosis lung disease patients
Background: Chronic pulmonary aspergillosis (CPA) complicates post-tuberculosis lung disease (PTLD), causing significant morbidity and mortality. Predictors for Aspergillus seropositivity and CPA in a PTLD population remain unclear. The objective of this study was to identify the clinical, radiological, physiological, and biochemical characteristics of patients presenting to an adult PTLD clinical service, who met full criteria for CPA, and to compare them to those who did not, as well as compare those with positive Aspergillus serology to those without. Methods: This retrospective cross-sectional study, performed in a tertiary adult PTLD clinical service in South Africa, investigated the clinical, radiological, physiological and biochemical characteristics of patients who had Aspergillus serology performed and compared those with positive and negative serology, as well as those meeting CPA diagnostic criteria with those who did not. Results: Over a 2-year period, 238 patients were seen in the PTLD clinic, of which 79 had registered Aspergillus immunoglobulin G (IgG) serology testing and computed tomography (CT) chest imaging performed. Twenty-six (32.9%) patients had positive Aspergillus serology and 20 (25.3%) met criteria for CPA. Current radiological definitions for CPA when applied in a blinded fashion, had a sensitivity of 80.8% and a specificity of 58.5% for Aspergillus seropositivity, with a positive predictive value of 48.8%. Having ≥4 episodes of previous pulmonary tuberculosis (PTB) was significantly associated with both Aspergillus seropositivity [odds ratio (OR) =10.9; 95% confidence interval (CI): 2.1–84.9] and CPA diagnosis (OR =15.5; 95% CI: 2.8–125.6). Haemoptysis was significantly more common in those with positive Aspergillus serology (OR =2.7; 95% CI: 1.4–5.2) and in those with CPA (OR =2.7; 95% CI: 1.4–5.4). Total immunoglobulin E (IgE) levels were significantly higher in those with Aspergillus seropositivity (P value =0.006) and in those with CPA (P value =0.03). Other symptoms, spirometric and laboratory findings were similar between groups. Conclusions: Current radiological criteria are not sufficiently specific for the diagnosis of CPA in PTLD populations, necessitating wider use of Aspergillus serology. The significant overlap in clinical syndromes highlights a complicated yet poorly understood relationship between CPA and PTLD, with increased frequency of haemoptysis requiring further research.
- 1 January 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (1) , 320-332
Open AccessA retrospective study exploring chronic pulmonary aspergillosis in post-tuberculosis lung disease patients
Background: Chronic pulmonary aspergillosis (CPA) complicates post-tuberculosis lung disease (PTLD), causing significant morbidity and mortality. Predictors for Aspergillus seropositivity and CPA in a PTLD population remain unclear. The objective of this study was to identify the clinical, radiological, physiological, and biochemical characteristics of patients presenting to an adult PTLD clinical service, who met full criteria for CPA, and to compare them to those who did not, as well as compare those with positive Aspergillus serology to those without. Methods: This retrospective cross-sectional study, performed in a tertiary adult PTLD clinical service in South Africa, investigated the clinical, radiological, physiological and biochemical characteristics of patients who had Aspergillus serology performed and compared those with positive and negative serology, as well as those meeting CPA diagnostic criteria with those who did not. Results: Over a 2-year period, 238 patients were seen in the PTLD clinic, of which 79 had registered Aspergillus immunoglobulin G (IgG) serology testing and computed tomography (CT) chest imaging performed. Twenty-six (32.9%) patients had positive Aspergillus serology and 20 (25.3%) met criteria for CPA. Current radiological definitions for CPA when applied in a blinded fashion, had a sensitivity of 80.8% and a specificity of 58.5% for Aspergillus seropositivity, with a positive predictive value of 48.8%. Having ≥4 episodes of previous pulmonary tuberculosis (PTB) was significantly associated with both Aspergillus seropositivity [odds ratio (OR) =10.9; 95% confidence interval (CI): 2.1–84.9] and CPA diagnosis (OR =15.5; 95% CI: 2.8–125.6). Haemoptysis was significantly more common in those with positive Aspergillus serology (OR =2.7; 95% CI: 1.4–5.2) and in those with CPA (OR =2.7; 95% CI: 1.4–5.4). Total immunoglobulin E (IgE) levels were significantly higher in those with Aspergillus seropositivity (P value =0.006) and in those with CPA (P value =0.03). Other symptoms, spirometric and laboratory findings were similar between groups. Conclusions: Current radiological criteria are not sufficiently specific for the diagnosis of CPA in PTLD populations, necessitating wider use of Aspergillus serology. The significant overlap in clinical syndromes highlights a complicated yet poorly understood relationship between CPA and PTLD, with increased frequency of haemoptysis requiring further research.
- 1 July 2021
- Published by Elsevier in Tuberculosis
- Vol. 129, 102107
Biomarkers to predict FDG PET/CT activity after the standard duration of treatment for spinal tuberculosis: An exploratory study
- 1 July 2021
- Published by Elsevier in Tuberculosis
- Vol. 129, 102107
Biomarkers to predict FDG PET/CT activity after the standard duration of treatment for spinal tuberculosis: An exploratory study
- Open Access
PROVE—Pre-Eclampsia Obstetric Adverse Events: Establishment of a Biobank and Database for Pre-Eclampsia
Pre-eclampsia is a leading cause of maternal and perinatal morbidity and mortality. The burden of disease lies mainly in low-middle income countries. The aim of this project is to establish a pre-eclampsia biobank in South Africa to facilitate research in the field of pre-eclampsia with a focus on phenotyping severe disease.The approach of our biobank is to collect biological specimens, detailed clinical data, tests, and biophysical examinations, including magnetic resonance imaging (MRI) of the brain, MRI of the heart, transcranial Doppler, echocardiography, and cognitive function tests.Women diagnosed with pre-eclampsia and normotensive controls are enrolled in the biobank at admission to Tygerberg University Hospital (Cape Town, South Africa). Biological samples and clinical data are collected at inclusion/delivery and during the hospital stay. Special investigations as per above are performed in a subset of women. After two months, women are followed up by telephonic interviews. This project aims to establish a biobank and database for severe organ complications of pre-eclampsia in a low-middle income country where the incidence of pre-eclampsia with organ complications is high. The study integrates different methods to investigate pre-eclampsia, focusing on improved understanding of pathophysiology, prediction of organ complications, and potentially future drug evaluation and discovery.
Open AccessPROVE—Pre-Eclampsia Obstetric Adverse Events: Establishment of a Biobank and Database for Pre-Eclampsia
Pre-eclampsia is a leading cause of maternal and perinatal morbidity and mortality. The burden of disease lies mainly in low-middle income countries. The aim of this project is to establish a pre-eclampsia biobank in South Africa to facilitate research in the field of pre-eclampsia with a focus on phenotyping severe disease.The approach of our biobank is to collect biological specimens, detailed clinical data, tests, and biophysical examinations, including magnetic resonance imaging (MRI) of the brain, MRI of the heart, transcranial Doppler, echocardiography, and cognitive function tests.Women diagnosed with pre-eclampsia and normotensive controls are enrolled in the biobank at admission to Tygerberg University Hospital (Cape Town, South Africa). Biological samples and clinical data are collected at inclusion/delivery and during the hospital stay. Special investigations as per above are performed in a subset of women. After two months, women are followed up by telephonic interviews. This project aims to establish a biobank and database for severe organ complications of pre-eclampsia in a low-middle income country where the incidence of pre-eclampsia with organ complications is high. The study integrates different methods to investigate pre-eclampsia, focusing on improved understanding of pathophysiology, prediction of organ complications, and potentially future drug evaluation and discovery.
- Open Access
- 10 February 2020
- Published by Springer Nature in EJNMMI Research
- Vol. 10 (1) , 1-15
Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response
Background: There is a growing interest in the use of F-18 FDG PET-CT to monitor tuberculosis (TB) treatment response. Tuberculosis lung lesions are often complex and diffuse, with dynamic changes during treatment and persisting metabolic activity after apparent clinical cure. This poses a challenge in quantifying scan-based markers of burden of disease and disease activity. We used semi-automated, whole lung quantification of lung lesions to analyse serial FDG PET-CT scans from the Catalysis TB Treatment Response Cohort to identify characteristics that best correlated with clinical and microbiological outcomes. Results: Quantified scan metrics were already associated with clinical outcomes at diagnosis and 1 month after treatment, with further improved accuracy to differentiate clinical outcomes after standard treatment duration (month 6). A high cavity volume showed the strongest association with a risk of treatment failure (AUC 0.81 to predict failure at diagnosis), while a suboptimal reduction of the total glycolytic activity in lung lesions during treatment had the strongest association with recurrent disease (AUC 0.8 to predict pooled unfavourable outcomes). During the first year after TB treatment lesion burden reduced; but for many patients, there were continued dynamic changes of individual lesions. Conclusions: Quantification of FDG PET-CT images better characterised TB treatment outcomes than qualitative scan patterns and robustly measured the burden of disease. In future, validated metrics may be used to stratify patients and help evaluate the effectiveness of TB treatment modalities.
- 10 February 2020
- Published by Springer Nature in EJNMMI Research
- Vol. 10 (1) , 1-15
Open AccessQuantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response
Background: There is a growing interest in the use of F-18 FDG PET-CT to monitor tuberculosis (TB) treatment response. Tuberculosis lung lesions are often complex and diffuse, with dynamic changes during treatment and persisting metabolic activity after apparent clinical cure. This poses a challenge in quantifying scan-based markers of burden of disease and disease activity. We used semi-automated, whole lung quantification of lung lesions to analyse serial FDG PET-CT scans from the Catalysis TB Treatment Response Cohort to identify characteristics that best correlated with clinical and microbiological outcomes. Results: Quantified scan metrics were already associated with clinical outcomes at diagnosis and 1 month after treatment, with further improved accuracy to differentiate clinical outcomes after standard treatment duration (month 6). A high cavity volume showed the strongest association with a risk of treatment failure (AUC 0.81 to predict failure at diagnosis), while a suboptimal reduction of the total glycolytic activity in lung lesions during treatment had the strongest association with recurrent disease (AUC 0.8 to predict pooled unfavourable outcomes). During the first year after TB treatment lesion burden reduced; but for many patients, there were continued dynamic changes of individual lesions. Conclusions: Quantification of FDG PET-CT images better characterised TB treatment outcomes than qualitative scan patterns and robustly measured the burden of disease. In future, validated metrics may be used to stratify patients and help evaluate the effectiveness of TB treatment modalities.
- 19 November 2019
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 29 (3) , 530-536
The Role of18F-FDG PET/CT in Suspected Intraocular Sarcoidosis and Tuberculosis
Purpose: To determine the utility of fluorine-18 fluorodeoxyglucose Positron Emission Tomography Computed Tomography (FDG PET/CT) in patients with suspected ocular sarcoidosis (OS) or intraocular tuberculosis (IOTB) in a resource-constrained, TB endemic area. Methods: Independent review of the FDG PET/CTs, Computed Tomography (CT) scans and chest radiographs (CXRs) of patients with suspected OS or IOTB and inconclusive conventional workup. Results: Twenty-nine PET/CTs and CXRs were reviewed, with 38% of PET/CTs and CTs demonstrating evidence of TB or sarcoidosis, compared to 21% of CXRs. The sensitivity, specificity, positive and negative predictive values for PET/CT and CT were similar - 85.7%, 95.5%, 85.7% and 95.5% for OS, and 33.3%, 100%, 100% and 68% for IOTB respectively and for CXR, 57.1%, 100%, 100% and 88% for OS, and 16.7%, 100%, 100% and 63% for IOTB. Conclusion: PET/CT added no significant additional benefit over Chest CT in patients with suspected OS or IOTB.
- 19 November 2019
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 29 (3) , 530-536
The Role of18F-FDG PET/CT in Suspected Intraocular Sarcoidosis and Tuberculosis
Purpose: To determine the utility of fluorine-18 fluorodeoxyglucose Positron Emission Tomography Computed Tomography (FDG PET/CT) in patients with suspected ocular sarcoidosis (OS) or intraocular tuberculosis (IOTB) in a resource-constrained, TB endemic area. Methods: Independent review of the FDG PET/CTs, Computed Tomography (CT) scans and chest radiographs (CXRs) of patients with suspected OS or IOTB and inconclusive conventional workup. Results: Twenty-nine PET/CTs and CXRs were reviewed, with 38% of PET/CTs and CTs demonstrating evidence of TB or sarcoidosis, compared to 21% of CXRs. The sensitivity, specificity, positive and negative predictive values for PET/CT and CT were similar - 85.7%, 95.5%, 85.7% and 95.5% for OS, and 33.3%, 100%, 100% and 68% for IOTB respectively and for CXR, 57.1%, 100%, 100% and 88% for OS, and 16.7%, 100%, 100% and 63% for IOTB. Conclusion: PET/CT added no significant additional benefit over Chest CT in patients with suspected OS or IOTB.
- Open Access
- 3 July 2018
- Published by Taylor & Francis in Southern African Journal of Gynaecological Oncology
- Vol. 10 (2) , 30-33
Ovarian germ cell tumour and bleomycin-induced lung injury
Bleomycin, an antibiotic agent with antitumour activity, is an important drug in the management of many oncological malignancies such as lymphoma and germ cell tumours. These tumours are potentially curable and mostly affect young people. The potential side effects and long-term toxicities should be considered. The major limitation of bleomycin therapy is pulmonary toxicity and may be life threatening in about 10% of cases. This article reports a case of an ovarian mixed germ cell tumour, which presented with bleomycin-associated pulmonary toxicity.
- 3 July 2018
- Published by Taylor & Francis in Southern African Journal of Gynaecological Oncology
- Vol. 10 (2) , 30-33
Open AccessOvarian germ cell tumour and bleomycin-induced lung injury
Bleomycin, an antibiotic agent with antitumour activity, is an important drug in the management of many oncological malignancies such as lymphoma and germ cell tumours. These tumours are potentially curable and mostly affect young people. The potential side effects and long-term toxicities should be considered. The major limitation of bleomycin therapy is pulmonary toxicity and may be life threatening in about 10% of cases. This article reports a case of an ovarian mixed germ cell tumour, which presented with bleomycin-associated pulmonary toxicity.
- Open Access
- 25 June 2018
- Published by Springer Nature in EJNMMI Research
- Vol. 8 (1) , 1-14
A semi-automatic technique to quantify complex tuberculous lung lesions on 18F-fluorodeoxyglucose positron emission tomography/computerised tomography images
There is a growing interest in the use of 18F-FDG PET-CT to monitor tuberculosis (TB) treatment response. However, TB causes complex and widespread pathology, which is challenging to segment and quantify in a reproducible manner. To address this, we developed a technique to standardise uptake (Z-score), segment and quantify tuberculous lung lesions on PET and CT concurrently, in order to track changes over time. We used open source tools and created a MATLAB script. The technique was optimised on a training set of five pulmonary tuberculosis (PTB) cases after standard TB therapy and 15 control patients with lesion-free lungs. We compared the proposed method to a fixed threshold (SUV > 1) and manual segmentation by two readers and piloted the technique successfully on scans of five control patients and five PTB cases (four cured and one failed treatment case), at diagnosis and after 1 and 6 months of treatment. There was a better correlation between the Z-score-based segmentation and manual segmentation than SUV > 1 and manual segmentation in terms of overall spatial overlap (measured in Dice similarity coefficient) and specificity (1 minus false positive volume fraction). However, SUV > 1 segmentation appeared more sensitive. Both the Z-score and SUV > 1 showed very low variability when measuring change over time. In addition, total glycolytic activity, calculated using segmentation by Z-score and lesion-to-background ratio, correlated well with traditional total glycolytic activity calculations. The technique quantified various PET and CT parameters, including the total glycolytic activity index, metabolic lesion volume, lesion volumes at different CT densities and combined PET and CT parameters. The quantified metrics showed a marked decrease in the cured cases, with changes already apparent at month one, but remained largely unchanged in the failed treatment case. Our technique is promising to segment and quantify the lung scans of pulmonary tuberculosis patients in a semi-automatic manner, appropriate for measuring treatment response. Further validation is required in larger cohorts.
- 25 June 2018
- Published by Springer Nature in EJNMMI Research
- Vol. 8 (1) , 1-14
Open AccessA semi-automatic technique to quantify complex tuberculous lung lesions on 18F-fluorodeoxyglucose positron emission tomography/computerised tomography images
There is a growing interest in the use of 18F-FDG PET-CT to monitor tuberculosis (TB) treatment response. However, TB causes complex and widespread pathology, which is challenging to segment and quantify in a reproducible manner. To address this, we developed a technique to standardise uptake (Z-score), segment and quantify tuberculous lung lesions on PET and CT concurrently, in order to track changes over time. We used open source tools and created a MATLAB script. The technique was optimised on a training set of five pulmonary tuberculosis (PTB) cases after standard TB therapy and 15 control patients with lesion-free lungs. We compared the proposed method to a fixed threshold (SUV > 1) and manual segmentation by two readers and piloted the technique successfully on scans of five control patients and five PTB cases (four cured and one failed treatment case), at diagnosis and after 1 and 6 months of treatment. There was a better correlation between the Z-score-based segmentation and manual segmentation than SUV > 1 and manual segmentation in terms of overall spatial overlap (measured in Dice similarity coefficient) and specificity (1 minus false positive volume fraction). However, SUV > 1 segmentation appeared more sensitive. Both the Z-score and SUV > 1 showed very low variability when measuring change over time. In addition, total glycolytic activity, calculated using segmentation by Z-score and lesion-to-background ratio, correlated well with traditional total glycolytic activity calculations. The technique quantified various PET and CT parameters, including the total glycolytic activity index, metabolic lesion volume, lesion volumes at different CT densities and combined PET and CT parameters. The quantified metrics showed a marked decrease in the cured cases, with changes already apparent at month one, but remained largely unchanged in the failed treatment case. Our technique is promising to segment and quantify the lung scans of pulmonary tuberculosis patients in a semi-automatic manner, appropriate for measuring treatment response. Further validation is required in larger cohorts.
- 26 May 2007
- Published by Springer Nature in Pediatric Radiology
- Vol. 37 (8) , 798-804
Cavitating pulmonary tuberculosis in children: correlating radiology with pathogenesis
Cavitating pulmonary tuberculosis (PTB) is generally known as a disease of adults, with children typically having features of primary PTB.
- 26 May 2007
- Published by Springer Nature in Pediatric Radiology
- Vol. 37 (8) , 798-804
Cavitating pulmonary tuberculosis in children: correlating radiology with pathogenesis
Cavitating pulmonary tuberculosis (PTB) is generally known as a disease of adults, with children typically having features of primary PTB.